Aera­mi Ther­a­peu­tics CEO Lisa Yañez pass­es away, chair to lead heart dis­ease biotech

Aera­mi Ther­a­peu­tics, which is work­ing on an in­haled ther­a­py for hy­per­ten­sion, said Fri­day morn­ing its CEO Lisa Yañez passed away ear­li­er this week.

Yañez, 50 …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.